Thermo Fisher Scientific Inc Lowers FY 2012 Revenue Guidance; Raises FY 2012 EPS Guidance

Thermo Fisher Scientific Inc updated fiscal 2012 guidance to reflect the Laboratory Workstations business as a discontinued operation, the acquisition of Doe & Ingalls and more unfavorable foreign exchange. As a result, it expects fiscal 2012, to generate revenue of $12.14-$12.26 billion. The Company is also raising adjusted EPS guidance to a new range of $4.74-$4.84, primarily to include the factors above as well as the new stock buyback authorization. The fiscal 2012 guidance does not include the impact of the pending acquisition of One Lambda nor any future acquisitions. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $12.33 billion and EPS of $4.79 for fiscal 2012.